Frankfurt - Delayed Quote EUR
Chimerix, Inc. (CXF.F)
7.48
0.00
(0.00%)
As of April 17 at 9:55:01 PM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALRUTZ MICHAEL ALBERT General Counsel | Sale | Feb 13, 2025 | 213,596 |
| ANDRIOLE MICHAEL T. Chief Executive Officer | Sale | Feb 13, 2025 | 609,603 |
| DEMSKI MARTHA J. Director | Purchase | May 10, 2023 | -- |
| JAKEMAN DAVID A Officer | Sale | Feb 13, 2025 | 148,987 |
| LASPALUTO MICHELLE Chief Financial Officer | Sale | Feb 13, 2025 | 172,977 |
| MELEMED ALLEN S Officer | Sale | Feb 13, 2025 | 152,875 |
| MEYER ROBERT JAMES M.D. Director | Purchase | May 8, 2023 | 35,150 |
| MIDDLETON FRED A Director | Stock Gift | Oct 28, 2024 | -- |
| RIGA THOMAS J. Chief Operating Officer | Stock Award(Grant) | Jan 7, 2025 | 57,501 |
| SHERMAN MICHAEL A Chief Executive Officer | Purchase | May 12, 2023 | -- |
Related Tickers
8C5.F Coherus BioSciences, Inc.
0.9502
+7.95%
4AJ0.BE Alk-Abello A/S
19.61
-0.36%
4QK.F Codexis, Inc.
1.9330
+4.71%
IPIX Innovation Pharmaceuticals Inc.
0.0005
+150.00%
NEUP Neuphoria Therapeutics Inc.
5.05
-2.88%
TSVT 2seventy bio, Inc.
4.9900
0.00%
AEON AEON Biopharma, Inc.
0.4050
+1.25%
ATOS Atossa Therapeutics, Inc.
0.6634
+4.21%